Incidence of hepatocellular carcinoma in patients with hepatitis C treated with direct-acting antivirals agents: results of a long-term prospective study period

被引：0
|
作者：
De Santis, Emanuela [1 ]
Caioli, Alessandro [1 ]
De Angelis, Fernando [1 ]
De Santis, Adriano [1 ]
机构：
[1] Sapienza Univ Rome, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-414
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [31] Risk of hepatocellular carcinoma and efficacy of direct-acting antivirals in patients with concurrent hepatitis C virus
    Harrod, Elizabeth
    Agarwal, Ritu
    Tabrizian, Parissa
    Rayapudi, Madhavi
    Ala, Aftab
    Fiel, Isabel
    Schwartz, Myron
    Dieterich, Douglas
    Friedman, Scott
    Saberi, Behnam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E733 - E734
  • [32] Outcomes of patients with chronic hepatitis C and hepatocellular carcinoma treated with direct-acting antivirals: Real-world experience
    Sriphoosanaphan, S.
    Ananchuensook, P.
    Siripon, N.
    Suksawatamnuay, S.
    Thaimai, P.
    Sittisomwong, S.
    Thanapirom, K.
    Komolmit, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 195 - 196
  • [33] Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
    Kishta, Sara
    Tabll, Ashraf
    Kolaric, Tea Omanovic
    Smolic, Robert
    Smolic, Martina
    BIOMEDICINES, 2020, 8 (06) : 1 - 15
  • [34] Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients
    Abdelaziz, Ashraf O.
    Nabil, Mohamed M.
    Abdelmaksoud, Ahmed H.
    Shousha, Hend I.
    Hashem, Mohamed B.
    Hassan, Eman M.
    Salah, Ayman
    Omran, Dalia A.
    Elbaz, Tamer M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 75 - 79
  • [35] Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
    Cabral, Loraine Kay D.
    Grisetti, Luca
    Pratama, Muhammad Yogi
    Tiribelli, Claudio
    Pascut, Devis
    CANCERS, 2022, 14 (11)
  • [36] Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study
    Gonzalez-Corvillo, Carmen
    Beneyto, Isabel
    Sanchez-Fructuoso, Ana
    Perello, Manel
    Alonso, Angel
    Mazuecos, Auxiliadora
    Jimenez, Carlos
    Zarraga, Sofia
    Paul, Javier
    Lauzurica, Ricardo
    Hernandez, Domingo
    Guirado, Luis
    Franco, Antonio
    Carlos Ruiz, Juan
    Llorente, Santiago
    Crespo, Marta
    Rodriguez-Benot, Alberto
    de Gracia Guindo, Maria del Carmen
    Diaz-Corte, Carmen
    Angel Gentil, Miguel
    TRANSPLANTATION DIRECT, 2019, 5 (12):
  • [37] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Ioanna Aggeletopoulou
    Christos Konstantakis
    Spilios Manolakopoulos
    Christos Triantos
    World Journal of Gastroenterology, 2017, (24) : 4317 - 4323
  • [38] Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia
    Chan, Patrick P. Y.
    Levy, Miriam T.
    Shackel, Nicholas
    Davison, Scott A.
    Prakoso, Emilia
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2020, 19 (06) : 541 - 546
  • [39] Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia
    Patrick P Y Chan
    Miriam T Levy
    Nicholas Shackel
    Scott A Davison
    Emilia Prakoso
    Hepatobiliary&PancreaticDiseasesInternational, 2020, 19 (06) : 541 - 546
  • [40] Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
    Aggeletopoulou, Ioanna
    Konstantakis, Christos
    Manolakopoulos, Spilios
    Triantos, Christos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (24) : 4317 - 4323
12345